Parameter
| Biomarker | MT-RNA | Full name | Mycobacterium tuberculosis RNA | Molecular Type | Nucleic acid（RNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis and surveillance |
| Disease | tuberculosis | Disease Subtypes | / | ||
| Organ | Lung | Test Sample / Technology Platform | Clinical Samples (RNA Detection Technology) | ||
| Pathobiological Mechanisms | MTB has a short lifespan of mRNA, and its concentration decreases reflect a reduction in pathogens after treatment, which can dynamically reflect disease changes | ||||
| Clinical Availability Status | Research validation: mRNA-based assays monitor pathogen changes during treatment | ||||
| Notes and Dynamics | It can reflect disease progression and treatment response in real time, and is suitable for dynamic monitoring of treatment effect | ||||